Incretin Atlas·MoleculesTrialsOutcomesTimelinePipelineAboutMedical Adviser's Group
Incretin Atlas › Molecules › Cotadutide

Cotadutide

GLP-1/GCG · s.c. · AstraZeneca

Data cut 12 November 2026 · page built 16 November 2026 · 0 trial arms · 0 trials with results · 3 registered trials · see on the pipeline board

Summary

Also known as
MEDI0382, AstraZeneca
Mechanism
GLP-1/GCG
Route
s.c.
Company
AstraZeneca
Highest development stage
phase 2
Status (as of data cut)
Phase 2 (MASH, CKD with T2D) completed; no phase 3 registered verify
Next milestone
—

Sources for the status

Indications: regulatory and evidence status

IndicationCodeStatusEvidence
Obesity0 no data
T2D0 no data
CV outcomes0 no data
CKD1 phase 2 / signalPhase 2 in CKD with T2DCotadutide phase 2 CKD
HFpEF0 no data
MASH1 phase 2 / signalPhase 2 in NASH with fibrosisCotadutide phase 2 NASH
Sleep apnoea0 no data
Knee OA0 no data
Alzheimer's0 no data

4 = approved / in a label (FDA, EMA or NMPA), 3 = positive phase 3, 2 = phase 3 ongoing or completed without public results, 1 = phase 2 or signal only, 0 = no data, −1 = negative phase 3/4. L = label, P = PubMed, T = registry.

Trial arms: weight, HbA1c and tolerability

No trial arms with extracted efficacy or tolerability data yet.

Registered trials (3)

From ClinicalTrials.gov and the atlas registry sweep; phase 3 and outcome trials first.

TrialIndicationPhaseStatusStart → primary completionnResultRegistry
PROXYMO-ADV
A Study to Evaluate the Safety and Efficacy of Cotadutide Given by Subcutaneous Injection in Adult Participants With Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis
MASHPhase 2completed2022-07 → 2024-0454Completed; results not in the atlas yetNCT05364931
NCT04515849
A Study of Cotadutide in Participants Who Have Chronic Kidney Disease With Type 2 Diabetes Mellitus
CKDPhase 2completed2020-08 → 2022-03248Completed; results not in the atlas yetNCT04515849
NCT04019561
A Study to Evaluate Safety and Pharmacodynamic Efficacy of 0382 in Obese Subjects With NAFLD/NASH.
MASHPhase 2completed2019-09 → 2021-0574Completed; results not in the atlas yetNCT04019561

Primary sources

No source recorded.

How to cite this page

Medical Adviser's Group. Incretin Atlas: Cotadutide. Data cut 12 November 2026. https://docs.mdwrt.app/infographics/incretin-atlas/cotadutide/ Data: doi:10.5281/zenodo.23473913. Accessed 16 November 2026.

Cite the primary publication for any single result; every value above links to it.